At a glance: Peppermint is Mentha × piperita L., a hybrid mint used as leaf and as essential oil. The distinction is crucial: the EMA classifies peppermint leaf for traditional relief of digestion-related complaints, while modern clinical trials in irritable bowel syndrome largely concern enteric-coated peppermint oil. Evidence for the oil cannot simply be transferred to peppermint tea.[1][2][3]
Botanical profile
- Accepted name: Mentha × piperita L.
- Common name: peppermint.
- Family: Lamiaceae.
- Medicinal parts: leaf (folium) and separately the essential oil (aetheroleum).
- EMA herbal drug names: Menthae piperitae folium and Menthae piperitae aetheroleum.[1][2]
Peppermint is a natural hybrid associated with watermint and spearmint ancestry. Like other mints, it bears opposite leaves, square stems and glandular structures that produce aromatic volatile oil.
Major constituent groups
Peppermint leaf contains both volatile and non-volatile constituents. Important groups include:
- Volatile oil monoterpenes, especially menthol and menthone, alongside menthyl acetate, 1,8-cineole and other terpenes.
- Phenolic acids, including rosmarinic acid.
- Flavonoids, including eriocitrin, luteolin derivatives and hesperidin-related compounds.[4][5]
The essential oil is a concentrated volatile fraction and therefore has a very different composition from a water infusion of the leaves.
Traditional use
Peppermint has traditionally been used as an aromatic digestive herb for indigestion, nausea, abdominal spasm, wind and a sense of fullness after food. Peppermint tea has also been used as a cooling, refreshing drink during minor febrile illnesses, while topical peppermint preparations have a long history of use for muscular discomfort and headache.
Contemporary herbal practice
Peppermint leaf remains a classic aromatic carminative in Western practice. Herbalists commonly use the infusion or tincture for bloating, wind, nausea and spasmodic digestive discomfort, often combining it with chamomile, fennel, meadowsweet or other digestive herbs according to the individual. Peppermint oil is treated as a separate, much more concentrated medicine rather than as a stronger version of the tea.
Peppermint leaf: regulatory evidence
The EMA HMPC concludes that peppermint leaf preparations may be used on the basis of traditional use for relief of digestion-related problems such as indigestion and flatulence. The agency explicitly notes that this conclusion is based on long-standing use rather than sufficient clinical-trial evidence.[1]
Laboratory findings suggesting relaxation of gastrointestinal smooth muscle and antispasmodic activity support biological plausibility, but they do not by themselves establish clinical effectiveness.[1]
Peppermint oil and irritable bowel syndrome
Clinical evidence is stronger for certain formulations of peppermint oil than for peppermint leaf tea. A 2022 systematic review and meta-analysis identified 10 randomised controlled trials involving 1,030 people with IBS. Peppermint oil performed better than placebo for global IBS symptoms and abdominal pain, but adverse events were more frequent and the authors rated the quality of evidence as very low.[3]
The practical lesson is not “peppermint cures IBS”. It is that a particular concentrated dosage form has been studied in a defined clinical population. Tea made from the leaves has different chemistry, exposure and trial evidence.
Pharmacology
Menthol can activate cold-sensitive TRPM8 ion channels, producing the characteristic cooling sensation. Peppermint oil and menthol also show smooth-muscle effects in experimental systems, helping explain interest in gastrointestinal spasm.[5]
Peppermint leaf also contains polyphenols not represented to the same degree in the essential oil. This is another reason not to treat “peppermint” as a single chemical intervention.
Preparations
- Dried leaf for infusion.
- Liquid and dry leaf extracts.
- Peppermint essential oil.
- Enteric-coated peppermint-oil capsules used in many gastrointestinal trials.
Enteric coating is not a cosmetic detail: it changes where the oil is released in the gastrointestinal tract and therefore matters when interpreting studies.
Safety
For peppermint leaf, the EMA lists worsening gastro-oesophageal reflux and heartburn among possible adverse effects and advises caution in people with gallstones or other biliary problems.[1]
Concentrated peppermint oil can cause different adverse effects from an ordinary infusion. Clinical trials in IBS have reported more adverse events with peppermint oil than placebo, with reflux-related symptoms among recognised concerns.[3]
Children, pregnancy and breastfeeding
Suitability depends on dosage form and age. Concentrated essential oils require greater caution than ordinary food exposure. For medicinal use in pregnancy, breastfeeding or young children, consult the relevant product monograph or a suitably qualified professional rather than extrapolating from culinary mint use.
Interactions and cautions
Reflux and biliary disease are more immediately relevant cautions for peppermint leaf than a long list of speculative drug interactions.[1] For concentrated oil preparations, formulation and dose matter. Medication review remains sensible where a person uses multiple medicines or has complex gastrointestinal disease.
Student note: common evidence traps
- Never cite an IBS peppermint-oil trial as evidence for peppermint tea.
- Do not combine the EMA leaf and essential-oil monographs as though they describe one preparation.
- Menthol pharmacology is relevant but is not the same thing as clinical evidence for whole peppermint preparations.
- A statistically significant pooled result can still come from very-low-quality evidence.
- Enteric coating is part of the intervention and should be recorded when appraising an IBS trial.
References
- European Medicines Agency, Committee on Herbal Medicinal Products. Menthae piperitae folium — Mentha × piperita L., folium. EU herbal monograph and assessment report. EMA. Revision published 2020; periodic review consultation 2026.
- European Medicines Agency, Committee on Herbal Medicinal Products. Menthae piperitae aetheroleum — Mentha × piperita L., aetheroleum. EU list entry, monograph and assessment report. EMA. Revision published 2020.
- Ingrosso MR, Ianiro G, Nee J, et al. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2022;56(6):932–941. doi:10.1111/apt.17179. PubMed.
- McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytotherapy Research. 2006;20(8):619–633. PubMed.
- Kazemi A, Iraji A, Esmaealzadeh N, et al. Peppermint and menthol: a review on their biochemistry, pharmacological activities, clinical applications, and safety considerations. Critical Reviews in Food Science and Nutrition. 2025;65(8):1553–1578. doi:10.1080/10408398.2023.2296991. PubMed.
Additional materia medica sources
- ESCOP. Menthae piperitae folium and Menthae piperitae aetheroleum, ESCOP Monographs.
- Blumenthal M, et al., eds. The Complete German Commission E Monographs. American Botanical Council; 1998.
- British Herbal Medicine Association. British Herbal Compendium, Volume 1 — Peppermint Leaf.
- Hoffmann D. Medical Herbalism. Healing Arts Press; 2003.
Last reviewed: 20 September 2026. Educational reference only; not an individual dosing or prescribing guide.
← Return to the Herbal Monograph Library | Herbal Medicine Safety and Interactions